{"id":"https://openalex.org/W2611367152","doi":"https://doi.org/10.1093/cid/cix198","title":"Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response","display_name":"Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response","publication_year":2017,"publication_date":"2017-05-02","ids":{"openalex":"https://openalex.org/W2611367152","doi":"https://doi.org/10.1093/cid/cix198","mag":"2611367152","pmid":"https://pubmed.ncbi.nlm.nih.gov/28472247","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5434340"},"language":"en","primary_location":{"id":"doi:10.1093/cid/cix198","doi":"https://doi.org/10.1093/cid/cix198","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/cix198","pdf_url":"https://academic.oup.com/cid/article-pdf/64/11/1557/17844296/cix198.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/cid/article-pdf/64/11/1557/17844296/cix198.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046323853","display_name":"Laura Lynn Kovanda","orcid":"https://orcid.org/0000-0002-4493-4652","observed_orcids":["https://orcid.org/0000-0002-4493-4652"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Laura L. Kovanda","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom;","Astellas Pharma Global Development, Inc, Northbrook, Illinois;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom;","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Astellas Pharma Global Development, Inc, Northbrook, Illinois;","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108028300","display_name":"Ruwanthi Kolamunnage\u2010Dona","orcid":"https://orcid.org/0000-0003-3886-6208","observed_orcids":["https://orcid.org/0000-0003-3886-6208"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ruwanthi Kolamunnage-Dona","raw_affiliation_strings":["Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, United Kingdom;","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026635936","display_name":"Michael Noel Neely","orcid":"https://orcid.org/0000-0002-1675-8276","observed_orcids":["https://orcid.org/0000-0002-1675-8276"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]},{"id":"https://openalex.org/I4405270452","display_name":"Saban Research Institute","ror":"https://ror.org/00qe7sv26","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405270452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Neely","raw_affiliation_strings":["Laboratory of Applied Pharmacokinetics and Bioinformatics, Saban Research Institute, and Division of Pediatric Infectious Diseases, Children\u2019s Hospital Los Angeles, University of Southern California; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Applied Pharmacokinetics and Bioinformatics, Saban Research Institute, and Division of Pediatric Infectious Diseases, Children\u2019s Hospital Los Angeles, University of Southern California; and","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626","https://openalex.org/I4405270452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086668079","display_name":"Johan A. Maertens","orcid":"https://orcid.org/0000-0003-4257-5980","observed_orcids":["https://orcid.org/0000-0003-4257-5980"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Johan Maertens","raw_affiliation_strings":["Universitaire Ziekenhuizen, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitaire Ziekenhuizen, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005787220","display_name":"Misun Lee","orcid":"https://orcid.org/0009-0003-0555-3093","observed_orcids":["https://orcid.org/0009-0003-0555-3093"]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Misun Lee","raw_affiliation_strings":["Astellas Pharma Global Development, Inc, Northbrook, Illinois;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Inc, Northbrook, Illinois;","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057302419","display_name":"William W. Hope","orcid":"https://orcid.org/0000-0001-6187-878X","observed_orcids":["https://orcid.org/0000-0001-6187-878X"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"William W. Hope","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom;","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5057302419"],"corresponding_institution_ids":["https://openalex.org/I146655781"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":{"value":4763,"currency":"USD","value_usd":4763},"fwci":5.6837,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.96711804,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"64","issue":"11","first_page":"1557","last_page":"1563"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isavuconazole","display_name":"isavuconazole","score":1.0},{"id":"https://openalex.org/keywords/invasive-aspergillosis","display_name":"invasive aspergillosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7799999713897705},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.8610000014305115},{"id":"https://openalex.org/keywords/mortality-prediction","display_name":"mortality prediction","score":0.7990000247955322},{"id":"https://openalex.org/keywords/antifungal-therapy","display_name":"antifungal therapy","score":0.8550000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8664853572845459},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8139966726303101},{"id":"https://openalex.org/C2780782397","wikidata":"https://www.wikidata.org/wiki/Q421603","display_name":"Galactomannan","level":3,"score":0.7078437209129333},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.37643373012542725},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2892517149448395},{"id":"https://openalex.org/C2776391196","wikidata":"https://www.wikidata.org/wiki/Q259626","display_name":"Aspergillosis","level":2,"score":0.2441401481628418},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2342858612537384},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18332815170288086}],"mesh":[{"descriptor_ui":"D000072742","descriptor_name":"Invasive Fungal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000072742","descriptor_name":"Invasive Fungal Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005690","descriptor_name":"Galactose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008351","descriptor_name":"Mannans","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055744","descriptor_name":"Invasive Pulmonary Aspergillosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055744","descriptor_name":"Invasive Pulmonary Aspergillosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D055744","descriptor_name":"Invasive Pulmonary Aspergillosis","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/cid/cix198","doi":"https://doi.org/10.1093/cid/cix198","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/cix198","pdf_url":"https://academic.oup.com/cid/article-pdf/64/11/1557/17844296/cix198.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5434340","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5434340","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Infect Dis","raw_type":"Text"},{"id":"pmid:28472247","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28472247","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/592712","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/592712","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Infectious Diseases, vol. 64 (11), (1557-1563)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1093/cid/cix198","doi":"https://doi.org/10.1093/cid/cix198","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/cix198","pdf_url":"https://academic.oup.com/cid/article-pdf/64/11/1557/17844296/cix198.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4021212198","display_name":null,"funder_award_id":"MR/M013227/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2611367152.pdf","grobid_xml":"https://content.openalex.org/works/W2611367152.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1891954670","https://openalex.org/W1908389770","https://openalex.org/W1974363908","https://openalex.org/W2005803431","https://openalex.org/W2015472317","https://openalex.org/W2021298363","https://openalex.org/W2066116069","https://openalex.org/W2076548141","https://openalex.org/W2080468965","https://openalex.org/W2094114209","https://openalex.org/W2105575181","https://openalex.org/W2124576035","https://openalex.org/W2130248951","https://openalex.org/W2135104889","https://openalex.org/W2139078639","https://openalex.org/W2144902349","https://openalex.org/W2152631534","https://openalex.org/W2161457899","https://openalex.org/W2189861011","https://openalex.org/W2228943116","https://openalex.org/W2252599312","https://openalex.org/W2264291980","https://openalex.org/W2284948484","https://openalex.org/W2348328890","https://openalex.org/W2394625609","https://openalex.org/W2470291098"],"related_works":["https://openalex.org/W2336101512","https://openalex.org/W2139078639","https://openalex.org/W2153754392","https://openalex.org/W2228943116","https://openalex.org/W2015472317","https://openalex.org/W4417212159","https://openalex.org/W7099518906","https://openalex.org/W2587611907","https://openalex.org/W7099542648","https://openalex.org/W4403629284"],"abstract_inverted_index":{"BACKGROUND.:":[0],"The":[1,101],"ability":[2],"to":[3,37,45,87,137,192,228],"make":[4],"early":[5,39],"therapeutic":[6,20],"decisions":[7],"when":[8],"treating":[9],"invasive":[10,73],"aspergillosis":[11],"using":[12],"changes":[13,40,230],"in":[14,41,79,111,194,207,223,231],"biomarkers":[15],"as":[16],"a":[17,64,195],"surrogate":[18],"for":[19,69,92,254,257],"response":[21],"could":[22,220],"significantly":[23,130],"improve":[24],"patient":[25,213],"outcome.":[26,214],"METHODS.:":[27],"Cox":[28],"proportional":[29],"hazards":[30],"model":[31],"and":[32,47,58,107,244,259],"logistic":[33],"regression":[34],"were":[35],"used":[36],"correlate":[38],"galactomannan":[42],"index":[43],"(GMI)":[44],"mortality":[46],"overall":[48,106],"response,":[49],"respectively,":[50],"from":[51,63,123,163],"patients":[52,80,105,110,258],"with":[53,81,139],"positive":[54,245],"baseline":[55,124],"GMI":[56,60,93,118,197,208,215],"(\u22650.5)":[57],"serial":[59],"during":[61],"treatment":[62,71],"phase":[65],"3":[66],"clinical":[67,226,260],"trial":[68],"the":[70,89,96,112,132,165,180,199],"of":[72,98,120,134,167,188,201,212,225],"mold":[74],"disease.":[75],"Pharmacokinetic/pharmacodynamic":[76],"(PK/PD)":[77],"analysis":[78],"isavuconazole":[82,109,202],"plasma":[83],"concentrations":[84],"was":[85],"conducted":[86],"establish":[88],"exposure":[90],"necessary":[91],"negativity":[94],"at":[95,198],"end":[97,200],"therapy.":[99,203],"RESULTS.:":[100],"study":[102],"included":[103],"158":[104],"78":[108],"PK/PD":[113],"modeling.":[114],"By":[115],"day":[116,161,218],"7,":[117],"increases":[119,143,216],">0.25":[121],"units":[122],"(3/130":[125],"survivors;":[126],"9/28":[127],"who":[128],"died)":[129],"increased":[131],"risk":[133],"death":[135],"compared":[136],"those":[138],"no":[140],"increase":[141],"or":[142],"<0.25":[144],"(hazard":[145],"ratio,":[146,172],"9.766;":[147],"95%":[148,174],"confidence":[149],"interval":[150],"[CI],":[151],"4.356-21.9;":[152],"P":[153],"<":[154],".0001).":[155],"For":[156],"each":[157],"unit":[158],"decrease":[159],"by":[160,217,242,247],"7":[162,219],"baseline,":[164],"odds":[166],"successful":[168],"therapy":[169,256],"doubled":[170],"(odds":[171],"2.154;":[173],"CI,":[175],"1.173-3.955).":[176],"An":[177],"area":[178],"under":[179],"concentration-versus-time":[181],"curve":[182],"over":[183],"half-maximal":[184],"effective":[185],"concentration":[186],"(AUC:EC50)":[187],"108.6":[189],"is":[190],"estimated":[191],"result":[193],"negative":[196],"CONCLUSIONS.:":[204],"Early":[205],"trends":[206],"are":[209],"highly":[210],"predictive":[211],"be":[221],"considered":[222],"context":[224],"signs":[227],"trigger":[229],"treatment,":[232],"once":[233],"validated.":[234],"Our":[235],"data":[236,250],"suggest":[237],"that":[238],"this":[239],"improves":[240],"survival":[241],"10-fold":[243],"outcome":[246],"3-fold.":[248],"These":[249],"have":[251],"important":[252],"implications":[253],"individualized":[255],"trials.":[261],"CLINICAL":[262],"TRIALS":[263],"REGISTRATION.:":[264],"NCT00412893.":[265]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-05-12T00:00:00"}